Need all Congresses? Press Enter for expanded results.

HB 1169

South Dakota - Session 71

House of Representatives enacted 2026-03-09
Bill Details

Title: classify medetomidine as a Schedule III controlled substance and establish permissible uses.

Summary

An Act to classify medetomidine as a Schedule III controlled substance and establish permissible uses.

Sponsor
Garcia, Josephine
Official Source Back to Bills
Support LegiList

Tracking state legislation? Support LegiList with a small contribution. Independent, ad-free, and built by one developer.

Payments are processed securely by Stripe in a separate window. LegiList never stores card details.
Actions Timeline
Date Event Detail
2026-01-27 Introduced Bill introduced
2026-03-09 Status enacted
2026-03-09 Latest Action Signed by the Governor
More Bills In Similar Categories
Bill Title Status
SB 39 revise provisions relating to industrial hemp. enacted
SB 42 enhance the penalties for ingestion, possession with intent to deliver, and delivery of a controlled substance in a state correctional facility. enacted
HB 1099 reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance. enacted
HB 1160 repeal the medical marijuana oversight committee. in_committee
HB 1065 revise the medical purpose affirmative defense in cannabis prosecution. passed_lower
HB 1255 require that the Department of Health accept the medical records of a veteran applying for a medical cannabis registry identification card. in_committee
HB 1211 create a digital registry identification card for medical cannabis patients. in_committee
SB 181 cause the repeal of the medical cannabis chapter upon the federal re-scheduling of cannabis. in_committee